Experts say there’s a myriad of factors behind the recent decrease in drug prices, and not all savings will be passed onto ...
A federal law, passed in 2024, bans imports of Russian uranium by 2028, increasing pressure to develop domestic fuel supplies ...
The Food and Drug Administration granted accelerated approval to Zenbexus, or iberdomide, in combination with daratumumab and ...
In the FMCG category, retail media is dominating the budgets, according to the report. In 2027, Warc predicts that retail ...
By one estimate, up to 86% of clinical trials don’t meet their recruitment targets during the trial time frame.
Stephen Farquhar is taking over as CEO of PHM, effective immediately, according to an internal email obtained by MM+M.
Citing ProPublica’s reporting, eight senators wrote a letter to Secretary of State Marco Rubio questioning the administration ...
Citing ProPublica’s reporting, eight senators wrote a letter to Secretary of State Marco Rubio questioning the administration ...
AbbVie’s Skyrizi maintained its advertising momentum across linear and streaming TV, while BlueChew generated nearly 400 ...
Azara Healthcare appointed Ashley Basile as chief strategy officer and Josh Taylor as chief revenue officer. J.P. Morgan Life ...
Moderna and Merck’s personalized mRNA cancer vaccine just cleared a huge hurdle. In the first positive Phase 3 trial for an ...
Vertex Pharmaceuticals’ Casgevy, known generically as exagamglogene autotemcel, is the first CRISPR/Cas9 gene-editing therapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results